Universe Pharmaceuticals Inc.
UPC · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,727 | -$6,581 | -$7,910 | $11,320 |
| Dep. & Amort. | $486 | $509 | $534 | $447 |
| Deferred Tax | $607 | $1,568 | -$542 | -$668 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$2,058 | $5,670 | $6,600 | -$12,686 |
| Other Non-Cash | $186 | -$46 | $6 | -$468 |
| Operating Cash Flow | -$9,507 | $1,120 | -$1,312 | -$2,056 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$246 | -$44 | -$94 | -$13,531 |
| Net Acquisitions | $0 | $0 | -$3,815 | $26,615 |
| Inv. Purchases | $0 | $0 | $0 | -$15,331 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $1,802 |
| Other Inv. Act. | -$115 | $0 | $1 | -$26,615 |
| Investing Cash Flow | -$361 | -$44 | -$3,908 | -$27,060 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8,954 | -$1,391 | $3,318 | $624 |
| Stock Issued | $25,000 | $0 | $0 | $28,750 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$2,793 |
| Financing Cash Flow | $33,954 | -$1,391 | $3,318 | $26,582 |
| Forex Effect | $126 | -$111 | -$464 | $554 |
| Net Chg. in Cash | $24,212 | -$426 | -$2,366 | -$1,980 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,285 | $5,711 | $8,078 | $10,058 |
| End Cash | $29,498 | $5,285 | $5,711 | $8,078 |
| Free Cash Flow | -$9,870 | $1,076 | -$1,406 | -$15,587 |